AETHLON MEDICAL INC vs. Boston Scientific Corp.
Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| AEMD | BSX | |
|---|---|---|
| Market Cap | $1.62 million | $69.81 billion |
| Revenue (TTM) | $759 | $21.00 billion |
| Net Income (TTM) | $-6,937,523 | $3.67 billion |
BSX leads on 3 of 3 size & scale factors.
Valuation
| AEMD | BSX | |
|---|---|---|
| P/E Ratio | — | 19.14 |
| Price / Book | 0.31 | 2.77 |
| Price / Sales | 2136.22 | 3.32 |
AEMD and BSX split the valuation factors evenly.
Profitability
| AEMD | BSX | |
|---|---|---|
| Net Margin | -914034.65% | 17.47% |
| Return on Equity | -133.43% | 14.58% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| AEMD | BSX | |
|---|---|---|
| Short Interest | 176.25% | 0.72% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: AEMD overview, AEMD financials, BSX overview, BSX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.